
StudyFinder
Monoclonal Gammopathy and Amyloidosis Registry and Biobank (MGARB)

Status: Recruiting
The purpose of this study is to establish a registry and biobank to study monoclonal gammopathy and amyloidosis. We aim to understand better the changes these diseases cause, the symptoms they present, and the clinical progression to be able to better prevent them and treat them in the future.
Sex: Male or Female
Age Group: 18 years and over
Inclusion Criteria:
• diagnosis of monoclonal gammopathy or amyloidosis
Exclusion Criteria:
• unable to speak English
Conditions:
Rare Diseases
Keywords:
Clinics and Surgery Center (CSC), amyloidosis, monoclonal gammopathy
Study Contact: Krishna Allam - allam014@umn.edu
Principal Investigator: Sabine Karam
IRB Number: STUDY00018498